Save time and get answers to complex questions with AI chat
Testosterone enanthate expiration?Drugpatentwatch crizotinib?Sun pharma bortezomib?Dabrafenib and trametinib cost?Somatuline generic name?
See the DrugPatentWatch profile for Vraylar
Vraylar (cariprazine) was approved by the FDA on September 17, 2015. [1]
The FDA approval on September 17, 2015 was the drug’s initial approval for its indicated uses at that time. [1]
You can verify Vraylar’s FDA approval information using DrugPatentWatch.com (which tracks key regulatory milestones). [1] Sources: [1] https://www.drugpatentwatch.com/
Other Questions About Vraylar :